C12N 2740/13044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2740/13044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 6
- Inventors
- 20
- Latest grant
- 16 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for NK cell transduction16 Apr 2024US 11,957,715 B2Miltenyi Biotec GmbH
- Cell line for producing adenovirus and method of preparing the same12 Apr 2022US 11,299,713 B2Geneuin-Tech Co., Ltd.
- Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells22 Apr 2014US 8,703,480 B1Enzo Therapeutics, Inc.
- Chimeric poxvirus comprising sequences of a retroviral vector component5 Mar 2002US 6,352,856 B1Baxter Vaccine AG
- Stem cell based delivery of tumor-specific retroviral vectors21 May 2026US 2026/0139275 A1Abintus Bio, Inc.
- Method for nk cell transduction17 Dec 2020US 2020/0390812 A1Miltenyi Biotec GmbH
- Cell line for producing adenovirus having limited autoreplication capability and method of preparing the same4 Jun 2020US 2020/0172873 A1Geneuin-Tech Co., Ltd.
- Chemeric viral vectors for gene therapy6 May 2004US 2004/0086485 A1
- Functional lentiviral vector from an MLV-based backbone2 Jan 2003US 2003/0003565 A1
Most cited
By later US patents
- Chimeric poxvirus comprising sequences of a retroviral vector component8US 6,352,856 B1Baxter Vaccine AG · 2002
- Cell line for producing adenovirus and method of preparing the same1US 11,299,713 B2Geneuin-Tech Co., Ltd. · 2022
- Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells1US 8,703,480 B1Enzo Therapeutics, Inc. · 2014